Kershaw, Lucy E; Lilburn, David ML; Jansen, Maurits A.; Bond, Andrew R; Alwahsh, Salamah M; Forbes, Shareen; Semple, Scott IK
(Journal of Magnetic Resonance Open, 2019)
Mangafodipir was approved for use as an MRI contrast agent in the late 1990s for liver and pancreas imaging but it was removed from the European market for commercial reasons in 2012. Previously, preliminary work in mice ...